Citius Pharmaceuticals Inc., of Maynard, Mass., said Leonard Mazur, its chairman and CEO, purchased 5 million restricted shares from the company for $3 million, enabling the company to continue to advance its product portfolio while enhancing its infrastructure to support the development of multiple candidates.